DEPIXOL

This brand name is authorized in Ireland, Malta, New Zealand, UK.

Active ingredients

The drug DEPIXOL contains one active pharmaceutical ingredient (API):

1
UNII 3B2FE28C1W - FLUPENTIXOL DECANOATE
 
Read more about Flupentixol

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 DEPIXOL Film-coated tablet MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 DEPIXOL Solution for injection MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
N05AF01 Flupentixol N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AF Thioxanthene derivatives
Discover more medicines within N05AF01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
GB Medicines & Healthcare Products Regulatory Agency 31014, 31024, 31033, 31042, 36800
IE Health Products Regulatory Authority 61816, 84069
MT Medicines Authority MA1323/00201, MA1323/00202
NZ Medicines and Medical Devices Safety Authority 2585, 2588

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈